{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T12:08:36Z","timestamp":1693742916108},"reference-count":10,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":341,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Apheresis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1002\/jca.21359","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T06:48:52Z","timestamp":1411627732000},"page":"58-59","source":"Crossref","is-referenced-by-count":3,"title":["Thrombotic thrombocytopenic purpura following terbinafine therapy"],"prefix":"10.1002","volume":"30","author":[{"given":"Kalman","family":"Filanovsky","sequence":"first","affiliation":[{"name":"Department of Hematology, Kaplan Medical Center; Rehovot, affiliated with Hadassah and Hebrew University Medical School; Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Sigler","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kaplan Medical Center; Rehovot, affiliated with Hadassah and Hebrew University Medical School; Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lev","family":"Shvidel","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kaplan Medical Center; Rehovot, affiliated with Hadassah and Hebrew University Medical School; Jerusalem Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"10.1002\/jca.21359-BIB0001|jca21359-cit-0001","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.amjmed.2007.03.021","article-title":"The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis","volume":"120","author":"Chang","year":"2007","journal-title":"Am J Med"},{"key":"10.1002\/jca.21359-BIB0002|jca21359-cit-0002","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2340\/00015555-1041","article-title":"Serious adverse events reporting on systemic terbinafine: a Danish register-based study","volume":"91","author":"Bangsgaard","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1002\/jca.21359-BIB0003|jca21359-cit-0003","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0190-9622(09)80049-2","article-title":"Neutropenia and pancytopenia associated with oral terbinafine","volume":"31","author":"Kovacs","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/jca.21359-BIB0004|jca21359-cit-0004","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenicpurpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/jca.21359-BIB0005|jca21359-cit-0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1002\/jca.21359-BIB0006|jca21359-cit-0006","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.1002\/jca.21359-BIB0007|jca21359-cit-0007","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1526-0968.2003.00127.x","article-title":"Drug-induced thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome: a concise review","volume":"8","author":"Dlott","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1002\/jca.21359-BIB0008|jca21359-cit-0008","first-page":"ECR34","article-title":"Thrombotic thrombocytopenic purpura associated with pegylated-interferon alpha-2a by an ADAMTS13 inhibitor in a patient with chronic hepatitis C","volume":"91","author":"Kitano","year":"2006","journal-title":"Haematologica"},{"key":"10.1002\/jca.21359-BIB0009|jca21359-cit-0009","unstructured":"2010"},{"key":"10.1002\/jca.21359-BIB0010|jca21359-cit-0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/j.1552-4604.1996.tb05032.x","article-title":"Pharmacokinetics and pharmacodynamics of multiple-dose terbinafine","volume":"36","author":"Nedelman","year":"1996","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Clinical Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjca.21359","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jca.21359\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T17:47:34Z","timestamp":1625507254000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.21359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1002\/jca.21359","relation":{},"ISSN":["0733-2459"],"issn-type":[{"value":"0733-2459","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,25]]}}}